Bliss GVS Pharma Limited (BOM:506197)

Bliss GVS Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 20, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	17,133	12,386	11,793	7,421	7,978	10,181
Market Cap Growth	-2.55%	5.03%	58.92%	-6.98%	-21.63%	-2.08%
Enterprise Value	16,010	11,511	11,487	7,314	7,890	10,302
Last Close Price	161.95	117.18	111.80	70.26	75.37	96.24
PE Ratio	15.69	14.69	15.63	10.47	53.05	14.86
Forward PE	-	6.57	6.57	6.57	6.57	6.57
PS Ratio	1.99	1.53	1.53	0.99	1.07	1.76
PB Ratio	1.47	1.13	1.18	0.81	0.94	1.23
P/TBV Ratio	1.52	1.19	1.23	0.85	0.98	1.27
P/FCF Ratio	26.47	41.50	15.83	-	12.98	18.56
P/OCF Ratio	12.61	11.70	11.47	21.63	5.89	15.92
PEG Ratio	-	0.29	0.29	0.29	0.29	0.29
EV/Sales Ratio	1.86	1.42	1.49	0.97	1.06	1.79
EV/EBITDA Ratio	12.98	9.42	7.77	6.31	6.77	9.88
EV/EBIT Ratio	17.52	11.83	9.25	7.42	7.79	11.52
EV/FCF Ratio	24.73	38.56	15.42	-	12.83	18.78
Debt / Equity Ratio	0.05	0.08	0.10	0.11	0.13	0.15
Debt / EBITDA Ratio	0.43	0.70	0.66	0.87	0.92	1.14
Debt / FCF Ratio	0.81	2.95	1.34	-	1.78	2.22
Asset Turnover	0.64	0.65	0.65	0.66	0.68	0.55
Inventory Turnover	3.52	3.53	3.62	3.64	3.62	3.90
Quick Ratio	3.46	3.45	3.55	2.38	2.32	2.66
Current Ratio	4.46	4.81	5.15	3.61	3.33	3.76
Return on Equity (ROE)	10.41%	8.62%	8.50%	8.70%	2.76%	9.37%
Return on Assets (ROA)	4.26%	4.84%	6.56%	5.44%	5.79%	5.31%
Return on Invested Capital (ROIC)	6.26%	6.98%	9.06%	8.05%	5.06%	7.37%
Return on Capital Employed (ROCE)	7.60%	8.60%	11.80%	10.20%	11.60%	10.20%
Earnings Yield	6.40%	6.81%	6.40%	9.55%	1.88%	6.73%
FCF Yield	3.78%	2.41%	6.32%	-8.02%	7.71%	5.39%
Dividend Yield	0.32%	0.43%	0.45%	0.71%	0.66%	0.52%
Payout Ratio	5.02%	6.46%	7.15%	7.67%	35.41%	8.10%
Buyback Yield / Dilution	0.09%	0.04%	-0.56%	-0.26%	0.26%	-2.26%
Total Shareholder Return	0.42%	0.46%	-0.11%	0.45%	0.92%	-1.74%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.